Author  
Place of duty  
Title   ¾Ï ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ½É³¶ »ïÃâ ( Pericardial Effusion in Malignant Cancer Patients )
Publicationinfo   1993 Jan; 025(04): 595-601.
Key_word   Pericardial effusion, Cancer patients
Full-Text  
Abstract   Pericardial effusion is not uncommon in patients with malignant tumor. Although most of patients with pericardial effusion are asymptamatic, early detection and appropriate treatment of this complication is important because of rapid progression to cardiac tamponade. We reviewed 30 cancer patients with pericardial effusion who were admitted to Kangnam St. Marys Hospital between May, 1982 and Oct, 1992. There were 13 men and 17 women. The medi- an age of these patients is 53(range 31-76). Lung and breast(2l cases, 70%) were predominant primary sites of underlying cancers. The common presenting symptoms and signs included dyspnea(100%), tachycardia(70%), cough/sputum(66.7%), tachypnea(66.7%), distant heart sound (60%), chest pain/discomfort(50%) and rale(50%). The most common abnormslities of chest x-ray and EKG were cardiomegaly(100%) and low voltage(60%), respectively. Echo free space on the 2-D echocardiograms was represented in all cases. Cytologic examination of pericardial fluid demonstrated malignant cells in 66.7%. Treatment modalities were conservative care 13 (43.3%), pericardial window formation 12(40%) and pericardiocentesis aione 5(16.7%), Overall median survival was 4.5 months. In conclusion, physicians should be always careful for the cancer patients who had symptom and signs suggesting pericardial effusion because early diagnosis by echocardiogram and appropriate selection of treatment modalities are essential for symptomatic relief and life prolongation.
Àú ÀÚ   ¹®Âù¼ö(Chan Soo Moon),Á¤Çؾï(Hae Uk Jung),¼Ûȣö(Ho Chul Song),°­Áø¿µ(Jin Hyung Kang),äÀ强(Jang Seoung Chae),±èÈƱ³(Hoon Kyo Kim),ÃÖ±Ôº¸(Kyu Bo Choi),ÀÌ°æ½Ä(Kyung Shik Lee),±èµ¿Áý(Dong Jip Kim)